394 related articles for article (PubMed ID: 15201738)
1. The relationship between renal tumor size and metastases in patients with von Hippel-Lindau disease.
Duffey BG; Choyke PL; Glenn G; Grubb RL; Venzon D; Linehan WM; Walther MM
J Urol; 2004 Jul; 172(1):63-5. PubMed ID: 15201738
[TBL] [Abstract][Full Text] [Related]
2. Renal cancer in families with hereditary renal cancer: prospective analysis of a tumor size threshold for renal parenchymal sparing surgery.
Walther MM; Choyke PL; Glenn G; Lyne JC; Rayford W; Venzon D; Linehan WM
J Urol; 1999 May; 161(5):1475-9. PubMed ID: 10210376
[TBL] [Abstract][Full Text] [Related]
3. Prevalence, morphology and biology of renal cell carcinoma in von Hippel-Lindau disease compared to sporadic renal cell carcinoma.
Neumann HP; Bender BU; Berger DP; Laubenberger J; Schultze-Seemann W; Wetterauer U; Ferstl FJ; Herbst EW; Schwarzkopf G; Hes FJ; Lips CJ; Lamiell JM; Masek O; Riegler P; Mueller B; Glavac D; Brauch H
J Urol; 1998 Oct; 160(4):1248-54. PubMed ID: 9751329
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous renal cryoablation of renal tumors in patients with von Hippel-Lindau disease.
Shingleton WB; Sewell PE
J Urol; 2002 Mar; 167(3):1268-70. PubMed ID: 11832711
[TBL] [Abstract][Full Text] [Related]
5. Nephron sparing surgery for renal cell carcinoma in von Hippel-Lindau disease.
Shinohara N; Nonomura K; Harabayashi T; Togashi M; Nagamori S; Koyanagi T
J Urol; 1995 Dec; 154(6):2016-9. PubMed ID: 7500447
[TBL] [Abstract][Full Text] [Related]
6. Parenchymal sparing surgery in patients with hereditary renal cell carcinoma: 10-year experience.
Herring JC; Enquist EG; Chernoff A; Linehan WM; Choyke PL; Walther MM
J Urol; 2001 Mar; 165(3):777-81. PubMed ID: 11176466
[TBL] [Abstract][Full Text] [Related]
7. Management and extended outcome of patients with synchronous bilateral solid renal neoplasms in the absence of von Hippel-Lindau disease.
Blute ML; Amling CL; Bryant SC; Zincke H
Mayo Clin Proc; 2000 Oct; 75(10):1020-6. PubMed ID: 11040850
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of von Hippel-Lindau disease with renal involvement].
Chrétien Y; Chauveau D; Richard S; Droz D; Correas JM; Mejean A; Dufour B; Grünfeld JP
Prog Urol; 1997 Dec; 7(6):939-47. PubMed ID: 9490138
[TBL] [Abstract][Full Text] [Related]
9. Metastases to hemangioblastomas in von Hippel-Lindau disease.
Jarrell ST; Vortmeyer AO; Linehan WM; Oldfield EH; Lonser RR
J Neurosurg; 2006 Aug; 105(2):256-63. PubMed ID: 17219831
[TBL] [Abstract][Full Text] [Related]
10. Nephron sparing surgery for renal cell carcinoma and von Hippel-Lindau's disease: a single center experience.
Roupret M; Hopirtean V; Mejean A; Thiounn N; Dufour B; Chretien Y; Chauveau D; Richard S
J Urol; 2003 Nov; 170(5):1752-5. PubMed ID: 14532769
[TBL] [Abstract][Full Text] [Related]
11. Parenchymal sparing surgery in patients with hereditary renal cell carcinoma.
Walther MM; Choyke PL; Weiss G; Manolatos C; Long J; Reiter R; Alexander RB; Linehan WM
J Urol; 1995 Mar; 153(3 Pt 2):913-6. PubMed ID: 7853573
[TBL] [Abstract][Full Text] [Related]
12. Nephron sparing surgery in von Hippel-Lindau associated renal cell carcinoma; clinicopathological long-term follow-up.
Jilg CA; Neumann HP; Gläsker S; Schäfer O; Leiber C; Ardelt PU; Schwardt M; Schultze-Seemann W
Fam Cancer; 2012 Sep; 11(3):387-94. PubMed ID: 22426863
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of microscopic lesions in grossly normal renal parenchyma from patients with von Hippel-Lindau disease, sporadic renal cell carcinoma and no renal disease: clinical implications.
Walther MM; Lubensky IA; Venzon D; Zbar B; Linehan WM
J Urol; 1995 Dec; 154(6):2010-4; discussion 2014-5. PubMed ID: 7500446
[TBL] [Abstract][Full Text] [Related]
14. The natural history of renal lesions in von Hippel-Lindau disease: a serial CT study in 28 patients.
Choyke PL; Glenn GM; Walther MM; Zbar B; Weiss GH; Alexander RB; Hayes WS; Long JP; Thakore KN; Linehan WM
AJR Am J Roentgenol; 1992 Dec; 159(6):1229-34. PubMed ID: 1442389
[TBL] [Abstract][Full Text] [Related]
15. [Surgical treatment of renal-cell carcinoma in von Hippel-Lindau disease].
Uscanga-Yépez J; Rodríguez-Covarrubias F; Morales J; Granados J; Gabilondo-Navarro F
Rev Invest Clin; 2013; 65(4):318-22. PubMed ID: 24304732
[TBL] [Abstract][Full Text] [Related]
16. Progress in nephron sparing therapy for renal cell carcinoma and von Hippel-Lindau disease.
Joly D; Méjean A; Corréas JM; Timsit MO; Verkarre V; Deveaux S; Landais P; Grünfeld JP; Richard S
J Urol; 2011 Jun; 185(6):2056-60. PubMed ID: 21496837
[TBL] [Abstract][Full Text] [Related]
17. Local recurrence after nephron-sparing surgery in von Hippel-Lindau disease.
Ploussard G; Droupy S; Ferlicot S; Ples R; Rocher L; Richard S; Benoit G
Urology; 2007 Sep; 70(3):435-9. PubMed ID: 17905091
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous radio frequency ablation of renal tumors in patients with von Hippel-Lindau disease: preliminary results.
Park BK; Kim CK
J Urol; 2010 May; 183(5):1703-7. PubMed ID: 20299060
[TBL] [Abstract][Full Text] [Related]
19. Surgical management of multi-organ visceral tumors in patients with von Hippel-Lindau disease: a single stage approach.
Hwang JJ; Uchio EM; Pavlovich CP; Pautler SE; Libutti SK; Linehan WM; Walther MM
J Urol; 2003 Mar; 169(3):895-8. PubMed ID: 12576808
[TBL] [Abstract][Full Text] [Related]
20. [Testicular metastasis and local recurrence of renal cell carcinoma after nephron-sparing surgery in von Hippel-Lindau disease].
Nemoto K; Shimizu H; Kimura G
Hinyokika Kiyo; 2007 Mar; 53(3):163-5. PubMed ID: 17447484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
